These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 21979598

  • 1. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
    Gatta LB, Berenzi A, Balzarini P, Dessy E, Angiero F, Alessandri G, Gambino A, Grigolato P, Benetti A.
    Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
    [Abstract] [Full Text] [Related]

  • 2. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH.
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [Abstract] [Full Text] [Related]

  • 3. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1.
    Zhong P, Li J, Gu Y, Liu Y, Wang A, Sun Y, Lu L.
    Int J Clin Exp Pathol; 2015 May; 8(3):2979-86. PubMed ID: 26045807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R, Giuşcă S, Căruntu ID, Gheorghiţă V, Neacşu D, Amălinei C.
    Rev Med Chir Soc Med Nat Iasi; 2010 May; 114(4):1118-24. PubMed ID: 21495457
    [Abstract] [Full Text] [Related]

  • 6. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ.
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [Abstract] [Full Text] [Related]

  • 7. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt M, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint W, Doorbar J.
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [Abstract] [Full Text] [Related]

  • 8. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y, Liu J, Gong L, Sun X, Long W.
    Virol J; 2019 Oct 16; 16(1):117. PubMed ID: 31619262
    [Abstract] [Full Text] [Related]

  • 9. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation.
    Kremer WW, Vink FJ, van Zummeren M, Dreyer G, Rozendaal L, Doorbar J, Bleeker MCG, Meijer CJLM.
    Mod Pathol; 2020 Oct 16; 33(10):1968-1978. PubMed ID: 32249820
    [Abstract] [Full Text] [Related]

  • 10. Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
    Hoshikawa S, Sano T, Yoshida T, Ito H, Oyama T, Fukuda T.
    Pathol Res Pract; 2010 Dec 15; 206(12):816-20. PubMed ID: 20965668
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS.
    Int J Med Sci; 2013 Dec 15; 10(12):1602-7. PubMed ID: 24151431
    [Abstract] [Full Text] [Related]

  • 13. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
    Jackson JA, Kapur U, Erşahin Ç.
    Int J Surg Pathol; 2012 Apr 15; 20(2):146-53. PubMed ID: 22104735
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
    Alshenawy HA.
    Pathol Res Pract; 2014 Dec 19; 210(12):916-21. PubMed ID: 25149503
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L, Wang L, Zhong J, Chen S.
    Cancer Cytopathol; 2010 Feb 25; 118(1):47-55. PubMed ID: 20069634
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y, Peng J, Yuan C, Mi X, Chen Z, Chen J, Chen A, Liu J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan 25; 36(1):63-68. PubMed ID: 32314725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.